发明申请
- 专利标题: Targeted infusion of agents for treatment of ALS
- 专利标题(中): 靶向输注用于治疗ALS的药剂
-
申请号: US11251548申请日: 2005-10-14
-
公开(公告)号: US20060094953A1公开(公告)日: 2006-05-04
- 发明人: Andreas Hartlep , Christoph Pedain
- 申请人: Andreas Hartlep , Christoph Pedain
- 主分类号: A61B5/05
- IPC分类号: A61B5/05
摘要:
A system and method for treating Amyotrophic Lateral Sclerosis (ALS) by delivery of an agent within the brain. At least one image of a target region is acquired, and at least one magnetic resonance diffusion tensor imaging (MR-DTI) scan of the target region is acquired. A diffusion tensor is calculated from the at least one MR-DTI scan, and at least one of an agent distribution and an agent concentration from the images and the calculated diffusion tensor is calculated. Using at least one of the calculated diffusion tensor, the images, the calculated agent distribution, and the calculated agent concentration, the placement of a delivery instrument is planned to deliver the agent to the target region to achieve a desired agent concentration and/or agent distribution within the target region.
公开/授权文献
- US09901413B2 Targeted infusion of agents for treatment of ALS 公开/授权日:2018-02-27
信息查询